Left Main Coronary Artery Percutaneous Coronary Intervention: Evolution and Results over Time

Left main coronary artery percutaneous coronary intervention (LMCA PCI) is a treatment option that is increasingly used in our setting. One of the reasons for choosing this therapeutic strategy is the improvements in devices and techniques. However, the long-term results of LMCA PCI are not well established.

Angioplastia al tronco de la coronaria izquierda: evolución y resultados en el tiempo

The aim of this retrospective study was to analyze UK data to assess the time trend of LMCA PCI and its clinical outcomes over a 9-year period.

Researchers analyzed 14,522 patients who underwent LMCA PCI between 2009 and 2017 in the UK. Changes in patient demographics were observed, with patients being older and with greater comorbidities. In addition, procedural complexity increased, either with greater number of vessels treated, bifurcation involvement, or greater number of stents used, and greater use of intravascular ultrasound and rotational atherectomy.

After adjustment, there was a significant reduction in the time to occurrence of periprocedural acute myocardial infarction (p < 0.001), in-hospital major cardiac or cerebrovascular events (p < 0.001), and procedural complications (p < 0.001).

Read also: TAVR and New Onset LBBB.

In a multivariate analysis, age, female sex, number of stents, and patient comorbidity were associated with higher rates of in-hospital cardiac or cerebrovascular events. Meanwhile, use intravascular imaging and year of PCI were associated with lower rates of major in-hospital events.

Conclusion

In patients with LMCA PCI, there were significant temporal changes with the increase in age and comorbidities. While the complexity of this intervention increases over the years, the rate of periprocedural acute myocardial infarction, major in-hospital events, and procedural complications decrease significantly over time. This information is of great help to the Heart Time when it comes to decision making regarding choosing a therapeutic strategy.

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the editorial board of SOLACI.org.

Original Title: Temporal Trends in In-Hospital Outcomes Following Unprotected Left-Main Percutaneous Coronary Intervention: An Analysis of 14522 Cases From British Cardiovascular Intervention Society Database 2009 to 2017.

Reference: Tim Kinnaird et al Circ Cardiovasc Interv. 2023;16:e012350.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....